| Financial Year |
March 31 2023 |
| Monetary Funds |
2,936,502,779.21 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
54,744,715.51 |
| Accounts Receivable |
4,167,805,790.78 |
| Advances to Suppliers |
465,398,956.72 |
| Other Receivables |
1,343,646,415.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,046,633,986.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
835,207,488.52 |
| Total Current Assets |
18,592,075,711.73 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
333,561,938.48 |
| Long-term Equity Investment |
158,832,824.07 |
| Investment Properties |
-- |
| Fixed Assetes |
1,285,358,403.79 |
| Under-construction Projects |
17,592,929.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
267,830,300.21 |
| R&D expenses |
-- |
| Goodwill |
164,538,013.20 |
| Long-Term Deferred and Prepaid Expenses |
84,357,163.40 |
| Deferred Income Tax Assets |
313,311,912.78 |
| Other Non-Current Assets |
2,494,271,583.18 |
| Sub-Total of Non-Current Assets |
5,386,426,818.85 |
| Total Assets |
23,978,502,530.58 |
| Short-Term Loans |
2,545,983,585.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,179,068,040.67 |
| Accounts Payable |
5,843,802,645.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,208,840.17 |
| Taxes Payable |
19,134,240.36 |
| Interest Payable |
-- |
| Dividend Payable |
989,545.89 |
| Other payables |
1,605,204,122.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
203,400,000.00 |
| Other Current Liabilities |
1,380,936,682.25 |
| Sub-Total of Current Liabilities |
17,070,621,581.38 |
| Long-term Loans |
1,204,000,000.00 |
| Bonds Payable |
500,995,276.56 |
| Long-Term Accounts Payable |
1,400,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,778,769,862.24 |
| Total Liabilities |
18,849,391,443.62 |
| Paid-In Capital(Or Share Stock) |
1,086,798,590.00 |
| Capital Surplus |
957,457,245.21 |
| Surplus Reserve |
128,523,796.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,020,495,930.67 |
| Minority Stockholder's Interest |
435,835,524.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,693,275,562.74 |
| Owner's Equity（Stockholder's Equity） |
5,129,111,086.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
23,978,502,530.58 |
